Telomir Pharmaceuticals, Inc.
TELO· Nasdaq
Telomir Pharmaceuticals, Inc.
- Last sale
- Oct 2, 2026 · +0.43%
- Market cap
- $80.81M
- 68.77M shares
- Filings
- 145
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $2,435,569 | reported | |
| FY 2024 | 2024-12-31 | $2,235,341 | reported | |
| FY 2023 | 2023-12-31 | $1,574,306 | reported | |
| FY 2022 | 2022-12-31 | $833,206 | reported |
Telomir Pharmaceuticals, Inc. · CIK 1971532 · Engraved from SEC EDGAR
